Clinical Trials
47
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (47 trials with phase data)• Click on a phase to view related trials
Phase II Clinical Clical of the Pure Protein Derivatives of BCG
- Conditions
- Tuberculosis
- Interventions
- Drug: Purified Protein Derivative of BCG（BCG-PPD）
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06975774
- Locations
- 🇨🇳
The Third People's Hospital Of Shenzhen, Shenzhen, Guangdong, China
Clinical Trials of Quadrivalent Influenza Vaccine
- Conditions
- Influenza, Human
- Interventions
- Biological: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant (low dose)Biological: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant placebo (low dose)Biological: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant (high dose)Biological: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant placebo (high dose)Biological: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Target Recruit Count
- 620
- Registration Number
- NCT06824519
- Locations
- 🇨🇳
Hebei Province Centers for Disease Control and Prevention, Shijiazhuang, Hebei, China
BCG for Therapeutic Use Phase Ⅲ Clinical Trial
- Conditions
- BCG
- Interventions
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Target Recruit Count
- 438
- Registration Number
- NCT06747455
- Locations
- 🇨🇳
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
🇨🇳The First Affiliated Hospital of USTC, Hefei, Anhui, China
🇨🇳Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing, Beijing, China
Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)
- Conditions
- Acute Gastroenteropathy Due to Norovirus
- Interventions
- Biological: quadrivalent recombinant norovirus vaccine (Pichia pastoris) placebo
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Target Recruit Count
- 6600
- Registration Number
- NCT06524947
- Locations
- 🇨🇳
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning, Guangxi, China
🇨🇳Hunan Center for Disease Control and Prevention, Changsha, Hunan, China
🇨🇳Sichuan Center for Disease Control and Prevention, Chengdu, Sichuan, China
BCG for Therapeutic Use Phase I Clinical Trial
- Conditions
- Non-muscular Invasive Bladder Cancer
- Interventions
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06100653
- Locations
- 🇨🇳
Hunan Cancer Hospital, Changsha, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next